• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含 APOBEC 的 HPV 阴性头颈部鳞状细胞癌中存在独特的免疫逃逸。

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.

机构信息

Core Unit Bioinformatics, Berlin Institute of Health (BIH), Berlin, Germany.

Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

出版信息

Int J Cancer. 2020 Oct 15;147(8):2293-2302. doi: 10.1002/ijc.33123. Epub 2020 Jun 18.

DOI:
10.1002/ijc.33123
PMID:32468570
Abstract

Immune checkpoint inhibition leads to response in some patients with head and neck squamous cell carcinoma (HNSCC). Robust biomarkers are lacking to date. We analyzed viral status, gene expression signatures, mutational load and mutational signatures in whole exome and RNA-sequencing data of the HNSCC TCGA dataset (n = 496) and a validation set (DKTK MASTER cohort, n = 10). Public single-cell gene expression data from 17 HPV-negative HNSCC were separately reanalyzed. APOBEC3-associated TCW motif mutations but not total single nucleotide variant burden were significantly associated with inflammation. This association was restricted to HPV-negative HNSCC samples. An APOBEC-enriched, HPV-negative subgroup was identified, that showed higher T-cell inflammation and immune checkpoint expression, as well as expression of APOBEC3 genes. Mutations in immune-evasion pathways were also enriched in these tumors. Analysis of single-cell sequencing data identified expression of APOBEC3B and 3C genes in malignant cells. We identified an APOBEC-enriched subgroup of HPV-negative HNSCC with a distinct immunogenic phenotype, potentially mediating response to immunotherapy.

摘要

免疫检查点抑制导致部分头颈部鳞状细胞癌 (HNSCC) 患者产生应答。但目前缺乏强大的生物标志物。我们分析了 HNSCC TCGA 数据集(n=496)和验证集(DKTK MASTER 队列,n=10)的全外显子组和 RNA 测序数据中的病毒状态、基因表达特征、突变负荷和突变特征。还分别重新分析了来自 17 例 HPV 阴性 HNSCC 的公共单细胞基因表达数据。APOBEC3 相关的 TCW 基序突变,而不是总单核苷酸变异负担,与炎症显著相关。这种关联仅限于 HPV 阴性 HNSCC 样本。鉴定出一个 APOBEC 富集、HPV 阴性亚组,其表现出更高的 T 细胞炎症和免疫检查点表达,以及 APOBEC3 基因的表达。这些肿瘤中还富集了免疫逃逸途径的突变。单细胞测序数据的分析鉴定出恶性细胞中 APOBEC3B 和 3C 基因的表达。我们鉴定出一个 APOBEC 富集的 HPV 阴性 HNSCC 亚组,具有独特的免疫原性表型,可能介导对免疫治疗的反应。

相似文献

1
Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.富含 APOBEC 的 HPV 阴性头颈部鳞状细胞癌中存在独特的免疫逃逸。
Int J Cancer. 2020 Oct 15;147(8):2293-2302. doi: 10.1002/ijc.33123. Epub 2020 Jun 18.
2
HPV Meets APOBEC: New Players in Head and Neck Cancer.HPV 遇上 APOBEC:头颈部癌症的新角色。
Int J Mol Sci. 2021 Jan 30;22(3):1402. doi: 10.3390/ijms22031402.
3
APOBEC mutagenesis is tightly linked to the immune landscape and immunotherapy biomarkers in head and neck squamous cell carcinoma.APOBEC 突变为头颈部鳞状细胞癌的免疫景观和免疫治疗生物标志物紧密相关。
Oral Oncol. 2019 Sep;96:140-147. doi: 10.1016/j.oraloncology.2019.07.020. Epub 2019 Jul 30.
4
Multi-modality analysis supports APOBEC as a major source of mutations in head and neck squamous cell carcinoma.多模态分析支持 APOBEC 作为头颈部鳞状细胞癌突变的主要来源。
Oral Oncol. 2017 Nov;74:8-14. doi: 10.1016/j.oraloncology.2017.09.002. Epub 2017 Sep 13.
5
Characterization of the tumor immune microenvironment in human papillomavirus-positive and -negative head and neck squamous cell carcinomas.人乳头瘤病毒阳性和阴性头颈部鳞状细胞癌的肿瘤免疫微环境特征。
Cancer Immunol Immunother. 2021 May;70(5):1227-1237. doi: 10.1007/s00262-020-02747-w. Epub 2020 Oct 30.
6
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas.PYHIN 基因作为人乳头瘤病毒阳性或阴性头颈部鳞状细胞癌预后的潜在生物标志物。
Mol Biol Rep. 2019 Jun;46(3):3333-3347. doi: 10.1007/s11033-019-04795-7. Epub 2019 Apr 12.
7
HPV33+ HNSCC is associated with poor prognosis and has unique genomic and immunologic landscapes.HPV33+ HNSCC 与预后不良相关,具有独特的基因组和免疫景观。
Oral Oncol. 2020 Jan;100:104488. doi: 10.1016/j.oraloncology.2019.104488. Epub 2019 Dec 10.
8
Human papillomavirus-encoded circular RNA circE7 promotes immune evasion in head and neck squamous cell carcinoma.人乳头瘤病毒编码的环状 RNA circE7 促进头颈部鳞状细胞癌的免疫逃逸。
Nat Commun. 2024 Oct 4;15(1):8609. doi: 10.1038/s41467-024-52981-4.
9
Patterns of antibody responses to nonviral cancer antigens in head and neck squamous cell carcinoma patients differ by human papillomavirus status.头颈部鳞状细胞癌患者针对非病毒癌症抗原的抗体反应模式因人类乳头瘤病毒状态而异。
Int J Cancer. 2019 Dec 15;145(12):3436-3444. doi: 10.1002/ijc.32623. Epub 2019 Aug 26.
10
HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.HPV 阳性状态与头颈部鳞状细胞癌中炎症性免疫微环境相关,并改善了对抗 PD-1 治疗的反应。
Sci Rep. 2019 Sep 16;9(1):13404. doi: 10.1038/s41598-019-49771-0.

引用本文的文献

1
Massive parallel sequencing of head and neck conventional squamous cell carcinomas: A comprehensive review.头颈部传统鳞状细胞癌的大规模平行测序:综述
Virchows Arch. 2024 Dec;485(6):965-976. doi: 10.1007/s00428-024-03987-2. Epub 2024 Nov 29.
2
Unravelling the Complexity of HNSCC Using Single-Cell Transcriptomics.利用单细胞转录组学揭示头颈部鳞状细胞癌的复杂性
Cancers (Basel). 2024 Sep 25;16(19):3265. doi: 10.3390/cancers16193265.
3
Genome-wide somatic mutation analysis of sinonasal adenocarcinoma with and without wood dust exposure.
有或无木尘暴露的鼻窦腺癌全基因组体细胞突变分析
Genes Environ. 2024 May 6;46(1):12. doi: 10.1186/s41021-024-00306-8.
4
Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma.头颈部鳞状细胞癌中免疫检查点阻断反应的临床基因组决定因素。
J Clin Invest. 2023 Oct 2;133(19):e169823. doi: 10.1172/JCI169823.
5
Unifying Different Cancer Theories in a Unique Tumour Model: Chronic Inflammation and Deaminases as Meeting Points.统一独特肿瘤模型中的不同癌症理论:慢性炎症和脱氨酶作为交汇点。
Int J Mol Sci. 2022 Aug 5;23(15):8720. doi: 10.3390/ijms23158720.
6
APOBEC3: Friend or Foe in Human Papillomavirus Infection and Oncogenesis?载脂蛋白 B mRNA 编辑酶催化多肽 3:人乳头瘤病毒感染和致癌中的朋友还是敌人?
Annu Rev Virol. 2022 Sep 29;9(1):375-395. doi: 10.1146/annurev-virology-092920-030354. Epub 2022 Jun 7.
7
Biomarkers and 3D models predicting response to immune checkpoint blockade in head and neck cancer (Review).用于预测头颈部癌症对免疫检查点阻断反应的生物标志物和 3D 模型(综述)。
Int J Oncol. 2022 Jul;61(1). doi: 10.3892/ijo.2022.5378. Epub 2022 Jun 1.
8
Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma.载脂蛋白B mRNA编辑酶催化多肽样蛋白(APOBECs)家族的综合生物信息学分析及APOBEC3D作为透明细胞肾细胞癌不良预后生物标志物的鉴定。
J Cancer. 2021 Oct 17;12(23):7101-7110. doi: 10.7150/jca.61972. eCollection 2021.
9
Immune-Related Mutational Landscape and Gene Signatures: Prognostic Value and Therapeutic Impact for Head and Neck Cancer.免疫相关突变图谱与基因特征:对头颈部癌的预后价值及治疗影响
Cancers (Basel). 2021 Mar 8;13(5):1162. doi: 10.3390/cancers13051162.
10
HPV Meets APOBEC: New Players in Head and Neck Cancer.HPV 遇上 APOBEC:头颈部癌症的新角色。
Int J Mol Sci. 2021 Jan 30;22(3):1402. doi: 10.3390/ijms22031402.